Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating proliferative disorders and other pathological conditions mediated by Bcr-Abl, c-Kit, DDR1, DDR2 or PDGF-R kinase activity

Method of treating proliferative disorders and other pathological conditions mediated by Bcr-Abl, c-Kit, DDR1, DDR2 or PDGF-R kinase activity

US Patent 9061029 · Granted Jun 23, 2015

Estimated economic value: $19,762,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical combinations2014
Pharmaceutical combinations2014
Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-ben2013
Pharmaceutical compounds2013
Pharmaceutical combinations2012